Does the Efficacy, Durability, and Safety of Faricimab for Diabetic Macular Edema in Randomized Trials Translate into Real-World Settings?
Saved in:
| Title: | Does the Efficacy, Durability, and Safety of Faricimab for Diabetic Macular Edema in Randomized Trials Translate into Real-World Settings? |
|---|---|
| Authors: | Peto T; School of Medicine, Dentistry and Biomedical Sciences, Queen's University Belfast, Belfast, UK., Vujosevic S; Eye Clinic, IRCCS MultiMedica, Milan, Italy.; Department of Biomedical, Surgical and Dental Sciences, University of Milan, Milan, Italy., Sheth V; University Retina and Macula Associates, Chicago, IL, USA., Downey A; F. Hoffmann-La Roche Ltd., Mississauga, ON, Canada., Gibson K; Roche Products Ltd., Welwyn Garden City, UK., Pollreisz A; Medical University of Vienna, Vienna, Austria. andreas.pollreisz@meduniwien.ac.at. |
| Source: | Ophthalmology and therapy [Ophthalmol Ther] 2025 Nov; Vol. 14 (11), pp. 2623-2629. Date of Electronic Publication: 2025 Sep 19. |
| Publication Type: | Editorial |
| Journal Info: | Publisher: Springer Healthcare Country of Publication: England NLM ID: 101634502 Publication Model: Print-Electronic Cited Medium: Print ISSN: 2193-8245 (Print) NLM ISO Abbreviation: Ophthalmol Ther Subsets: PubMed not MEDLINE |
| Database: | MEDLINE Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
| ISSN: | 2193-8245 |
|---|---|
| DOI: | 10.1007/s40123-025-01233-9 |
